Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced malignancies, including non-small cell lung cancer (NSCLC). These agents have improved clinical outcomes and have become quite an attractive alternative alone or combined with other treatments. Although ICIs are tolera...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaddepally, Raju, Doddamani, Rajiv, Sodavarapu, Soujanya, Madam, Narasa Raju, Katkar, Rujuta, Kutadi, Anupama P., Mathew, Nibu, Garje, Rohan, Chandra, Abhinav B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027181/
https://www.ncbi.nlm.nih.gov/pubmed/35453540
http://dx.doi.org/10.3390/biomedicines10040790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027181/
https://www.ncbi.nlm.nih.gov/pubmed/35453540
http://dx.doi.org/10.3390/biomedicines10040790

Ejemplares similares